Christian Elze serves as Executive at Protalix BioTherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Christian Elze has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 3, 2025 involved receiving (via award) 7,500 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 3, 2025 | PLX | $0 | Award | 7,500 | $N/A | Discretionary |
Christian Elze currently holds 7,500 shares of Protalix BioTherapeutics, Inc. (PLX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christian Elze has been a net neutral trader of PLX stock. They have purchased $0 and sold $0 worth of shares.
Christian Elze's most recent insider trade was on Sep 3, 2025, when they sold 7,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted